ArticleOncology letters2019

Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC.

Qian Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.